跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DALACIN C clindamycin (as hydrochloride) 150mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
DALACIN C clindamycin (as hydrochloride) 150mg capsule blister pack
Approved
STANDARD
DALACIN C clindamycin (as hydrochloride) 150mg capsule blister pack
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
0b836a7a3829b45f
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0b836a7a3829b45f
Product Name
DALACIN C clindamycin (as hydrochloride) 150mg capsule blister pack
Artg Id
12275
Artg Name
DALACIN C clindamycin (as hydrochloride) 150mg capsule blister pack
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/14045725aaca6f7d41cd4428eddaf6dd.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b505f060edbfae23c78a8ebf2f981985.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
0b836a7a3829b45f
Type
Standard
Back to TGA Approvals
